Mark A. Gohr
Financieel Directeur/CFO bij ANTH1, Inc.
Profiel
Mark A.
Gohr is currently the Chief Financial & Accounting Officer at ANTH1, Inc. He completed his undergraduate degree at Hastings College and his graduate degree at The University of Colorado.
Actieve functies van Mark A. Gohr
| Bedrijven | Functie | Begin |
|---|---|---|
ANTH1, Inc.
 ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Financieel Directeur/CFO | 17-06-2010 |
Opleiding van Mark A. Gohr
| The University of Colorado | Graduate Degree |
| Hastings College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
ANTH1, Inc.
ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Health Technology |
